Fate Therapeutics Company
Fate Therapeutics is a stem cell and developmental biology research company using biological mechanisms to develop stem cell therapeutics.
Investors
Technology:
Cell therapy, Stem cell therapy, mHealth
Industry:
Genomic and Epigenominc Instabillity, Public
Headquarters:
La Jolla, California, United States
Founded Date:
2007-01-01
Employees Number:
101-250
Funding Status:
IPO
Investors Number:
8
Total Funding:
1240928348
Estimated Revenue:
$50M to $100M
Last Funding Date:
2021-01-04
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership